After License Deal for Letermovir: Head-to-head Phase 2 Trial Initiated by AiCuris to Demonstrate Superiority of its Novel Drug Pritelivir vs. Valacyclovir for Treatment of Genital Herpes

After License Deal for Letermovir: Head-to-head Phase 2 Trial Initiated by AiCuris to Demonstrate Superiority of its Novel Drug Pritelivir vs.